Is Hims & Hers Health Inc (HIMS) a risky stock?
As of July 27, 2026, Clavix grades Hims & Hers Health Inc (HIMS) D for risk, a composite score of 38 out of 100 on an A+ to F scale, which puts HIMS in the "elevated risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
HIMS price, last 3 months
HIMS's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind HIMS's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how HIMS scores on each, as of July 27, 2026.
What's moving HIMS's risk right now
Company-specific signals Clavix flags behind HIMS's current grade, drawn from recent news and filings as of July 27, 2026.
An FDA advisory panel backed 4 peptides, potentially opening a $440M market for Hims per Leerink. But Martin Shkreli disclosed a short position, shares fell 6.7% on light volume, and the stock is up 313% over several years.
Hims's Chief Accounting Officer is departing, creating near-term financial reporting risk during a leadership transition. Separately, an FDA shift on peptides could expand Hims's market if finalized.
Recent HIMS news
The latest headlines Clavix ingested for Hims & Hers Health Inc, newest first. These feed the news-sentiment dimension of HIMS's grade.
-
Hims & Hers Health (HIMS) shares have gained 312.9% over five years, and a discounted cash flow analysis suggests the stock may still trade below intrinsic value, despite an ongoing debate over whether past gains have already captured the rerating.
-
Truist Financial raised its price target on Hims & Hers Health (NYSE:HIMS) from $23.00 to $27.00 while maintaining a 'hold' rating. The new target still suggests a potential 5.01% downside from the current price.
What a D grade means
On the Clavix A+ to F scale, HIMS's composite of 38 falls in the D band (35–49), read as "elevated risk." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell HIMS or any security. Grades are risk indicators, not predictions of return. Data may be delayed.